Related references
Note: Only part of the references are listed.Assessment of the role of zinc in the prevention of COVID-19 infections and mortality: A retrospective study in the Asian and European population
Nurshad Ali et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Efficacy and tolerability of bevacizumab in patients with severe Covid-19
Jiaojiao Pang et al.
NATURE COMMUNICATIONS (2021)
Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19
Ki Kwang Oh et al.
SCIENTIFIC REPORTS (2021)
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies
Paolo Fagone et al.
AUTOIMMUNITY REVIEWS (2020)
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study
Junmei Wang
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
Sara Mastaglio et al.
CLINICAL IMMUNOLOGY (2020)
Host transcriptome-guided drug repurposing for COVID-19 treatmen a meta-analysis based approach
Tamizhini Loganathan et al.
PEERJ (2020)
COVID-19: Poor outcomes in patients with zinc deficiency
Dinesh Jothimani et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
Aartjan J. W. Te Velthuis et al.
PLOS PATHOGENS (2010)